Related references
Note: Only part of the references are listed.An update of current treatments for adult acute myeloid leukemia
Herve Dombret et al.
BLOOD (2016)
Phase 2 study of the bispecific T-cell engager (BiTE) antibody blinatumomab in relapsed/refractory diffuse large B-cell lymphoma
A. Viardot et al.
BLOOD (2016)
Efficient CRISPR-Cas9 mediated gene disruption in primary erythroid progenitor cells
Hojun Li et al.
HAEMATOLOGICA (2016)
Efficient CRISPR-Cas9 mediated gene disruption in primary erythroid progenitor cells
Hojun Li et al.
HAEMATOLOGICA (2016)
The importance of the tumor microenvironment in the therapeutic management of cancer
Charles Pottier et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2015)
Efficacy of phosphatidylinositol-3 kinase inhibitors with diverse isoform selectivity profiles for inhibiting the survival of chronic lymphocytic leukemia cells
Elisa Goeckeritz et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
TLR-9 and IL-15 Synergy Promotes the In Vitro Clonal Expansion of Chronic Lymphocytic Leukemia B Cells
Patricia K. A. Mongini et al.
JOURNAL OF IMMUNOLOGY (2015)
Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study
Max S. Topp et al.
LANCET ONCOLOGY (2015)
Profile of blinatumomab and its potential in the treatment of relapsed/refractory acute lymphoblastic leukemia
Josep-Maria Ribera et al.
ONCOTARGETS AND THERAPY (2015)
Pharmacological Profiles of Acute Myeloid Leukemia Treatments in Patient Samples by Automated Flow Cytometry: A Bridge to Individualized Medicine
Teresa A. Bennett et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2014)
Modeling the tumor extracellular matrix: Tissue engineering tools repurposed towards new frontiers in cancer biology
Bartley J. Gill et al.
JOURNAL OF BIOMECHANICS (2014)
Chronic Lymphocytic Leukemia Cells in a Lymph Node Microenvironment Depict Molecular Signature Associated with an Aggressive Disease
Amit K. Mittal et al.
MOLECULAR MEDICINE (2014)
Ibrutinib, Obinutuzumab, Idelalisib, and Beyond: Review of Novel and Evolving Therapies for Chronic Lymphocytic Leukemia
Clement Chung et al.
PHARMACOTHERAPY (2014)
IL-21 and CD40L signals from autologous T cells can induce antigen-independent proliferation of CLL cells
Maria Fernanda Pascutti et al.
BLOOD (2013)
Targeting the Tumor Microenvironment for Cancer Therapy
Nor Eddine Sounni et al.
CLINICAL CHEMISTRY (2013)
Individualized tumor response testing profile has a prognostic value in childhood acute leukemias: multicenter non-interventional long-term follow-up study
Magdalena Piatkowska et al.
LEUKEMIA & LYMPHOMA (2013)
The role of tumour-stromal interactions in modifying drug response: challenges and opportunities
Douglas W. McMillin et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Bridging the Gap: Moving Predictive and Prognostic Assays from Research to Clinical Use
P. Michael Williams et al.
CLINICAL CANCER RESEARCH (2012)
EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols
T. Kalina et al.
LEUKEMIA (2012)
EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes
J. J. M. van Dongen et al.
LEUKEMIA (2012)
Stromal control of cystine metabolism promotes cancer cell survival in chronic lymphocytic leukaemia
Wan Zhang et al.
NATURE CELL BIOLOGY (2012)
Interaction with Vascular Endothelium Enhances Survival in Primary Chronic Lymphocytic Leukemia Cells via NF-kB Activation and De novo Gene Transcription
Andrea G. S. Buggins et al.
CANCER RESEARCH (2010)
Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
Ting-Chao Chou
CANCER RESEARCH (2010)
Novel Single-Platform Multiparameter FCM Analysis of Apoptosis: Significant Differences Between Wash and No-Wash Procedure
Julia Stemberger et al.
CYTOMETRY PART A (2010)
Diverse marrow stromal cells protect CLL cells from spontaneous and drug-induced apoptosis: development of a reliable and reproducible system to assess stromal cell adhesion-mediated drug resistance
Antonina V. Kurtova et al.
BLOOD (2009)
Drug cross-resistance and therapy-induced resistance in chronic lymphocytic leukaemia by an enhanced method of individualised tumour response testing
Andrew G. Bosanquet et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Bi-directional activation between mesenchymal stem cells and CLL B-cells: implication for CLL disease progression
Wei Ding et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
SCIENCE AND SOCIETY Challenges of translating genetic tests into clinical and public health practice
Wolf H. Rogowski et al.
NATURE REVIEWS GENETICS (2009)
Topoisomerase II alpha expression in acute myeloid leukaemia cells that survive after exposure to daunorubicin or ara-C
Elisabet Tina et al.
ONCOLOGY REPORTS (2009)
Increased levels of apoptosis of leukocyte subsets in cultured PBMCs compared to whole blood as shown by annexin V binding: Relevance to cytokine production
G Hodge et al.
CYTOKINE (2000)
Share Paper
